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Abstract
Purpose: The purpose of this study is to assess the feasibility and usefulness of time-resolved magnetic resonance 
angiography (TR-MRA) for follow-up of visceral artery aneurysms (VAAs) after embolotherapy.
Material and methods: Twenty-one VAAs (11 splenic, six renal, three internal iliac, and one superior pancreaticoduo-
denal artery aneurysms) in 18 patients (median age, 64 years; range, 36-88 years) previously treated by embolisation 
with platinum coils, were evaluated. The mean size of the aneurysm was 10.5 cm3 (range, 0.3-132 cm3). Among them, 
19 lesions were treated by aneurysmal packing with or without distal-to-proximal embolisation. For the remaining 
two lesions, distal-to-proximal embolization alone was performed. The mean observation period after embolotherapy 
was 35 weeks (range, 4-216). All patients underwent TR-MRA following an intravenous bolus injection of gadolinium 
chelate. Recanalisation was diagnosed when any portion of the aneurysmal sac was enhanced in the arterial phase.
Results: On TR-MRA, two lesions were diagnosed as recanalised. They were confirmed by transcatheter arteriography 
and re-treated by embolotherapy. For the remaining 19 lesions, there were no findings of recanalisation on TR-MRA. 
Conclusions: TR-MRA appears to be a feasible method for follow-up examination of VAAs treated by embolotherapy.
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Introduction
Owing to the increased use of cross-sectional imaging and 
an aging population, visceral artery aneurysms (VAAs) are 
now more frequently diagnosed than before. The report-
ed incidence is approximately 0.01% to 2% in autopsy and 
angiographic studies [1]. They are clinically important be-
cause of the high incidence of rupture and life-threatening 
haemorrhage associated with mortality rates of 20-75%, 
depending on the location of the aneurysm [2]. Consid-
ering the natural history of VAAs and the risk of rupture, 
the general consensus in the literature is to treat such le-
sions even when patients are asymptomatic [3]. Although 
endovascular procedures are used increasingly often for 
the treatment of aneurysms, recanalisation due to coil 
compaction and/or aneurysm regrowth (9-26%) remains 
a limitation of this method and requires long-term imag-
ing follow-up [4-6]. 
Digital subtraction angiography (DSA) is an invasive 
procedure that involves risks of complications such as 
formation of a pseudoaneurysm at the puncture site and 
arterial dissection and/or occlusion due to endothelial 
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injury caused by mal-manipulation of catheters or guide-
wires. Computed tomography angiography (CTA) is very 
effective in detecting aneurysms; however, metal artefacts 
limit its use after coil embolisation. Recently, time-resolved 
magnetic resonance angiography (TR-MRA) has been 
reported as a valuable option for noninvasive follow-up 
because it offers a noninvasive, high-temporal-resolution 
alternative to DSA for screening after coil embolisation [7]. 
In this study, we followed-up VAAs treated with coil em-




The protocol for this study was approved by our insti-
tutional review board. Twenty-one VAAs (11 splenic, 
six renal, three internal iliac, and one superior pancrea-
ticoduodenal artery aneurysms) in 18 patients (median 
age 64 years, range 36-88 years), treated by embolotherapy 
with 0.014 to 0.018-inch platinum coils with or without 
nylon or polyester fibres from January 2008 to March 
2016, were evaluated. All the patients had undergone 
contrast-enhanced CTA before treatment, and the lesions 
were measured on 1-mm-thickness images at the arterial 
phase. The volumes of the aneurysms were measured and 
calculated as described in the following section. Among 
the 21 lesions, 19 were treated by aneurysmal packing 
with or without distal-to-proximal embolisation, and the 
remaining two lesions were treated by distal-to-proximal 
embolisation alone. For lesions treated with aneurysmal 
packing alone (n = 15), packing density was calculated as 
described in the following section. All patients underwent 
TR-MRA as described in the separate section. 
Calculation of visceral artery aneurysm volume 
and coil-packing density
Theoretical coil-packing density (CPD) was calculated us-
ing the formula: CPD = 100 × (total coil volume/targeted 
VAA volume). Total coil volumes were calculated assuming 
a cylindrical coil shape, using the formula: coil volume = 
= π x (coil radius)2 × (coil length) for each coil. The VAA 
volume was measured on pre-treatment CTA and calculated 
using the formula: VAA volume = (4/3) × π x (length/2) × 
× (width/2) × (height/2). 
Time-resolved magnetic resonance angiography
All TR-MRA were performed on a 1.5-T MR system 
(Achieva: Philips Healthcare, Best, the Netherlands) or 
a 3.0-T system (Skyra: Siemens, Erlangen, Germany; or 
Ingenia: Philips Healthcare). TR-MRA was acquired with 
a 3D-T1-weighted gradient recalled echo sequence with 
the following parameters: for Achieva, TR/TE = 4.7/1.4 ms, 
flip angle (FA) = 40, field of view (FOV) = 400 mm 
with 80% rectangular FOV, matrix = 336 × 227, slice thick-
ness (ST) = 4 mm interpolated to 2.0 mm, slice number 
(SN) = 25, and slab thickness = 50 mm; for Skyra, TR/TE 
= 2.1/0.9 ms, FA = 10, FOV = 430 mm, matrix = 320 × 320, 
ST = 2 mm, SN = 40, and slab thickness = 80.0 mm; and 
for Ingenia, TR/TE = 2.7/0.9 ms, FA = 8, FOV = 450 mm 
with 70% rectangular FOV, matrix = 352 × 264, ST = 3 mm 
interpolated to 1.5 mm, SN = 40, and slab thickness = 60 mm. 
To reduce the number of in-plane phase-encoding steps, 
parallel imaging and keyhole imaging techniques were 
applied with a parallel imaging factor of 2.5 and keyhole 
factor of 20% for Achieva, and 3 and 10% with a sampling 
density of 20% for Skyra, respectively, and factors of 4 and 
25% for Ingenia, achieving temporal resolutions of 1.7, 1.05, 
and 1.7 s, respectively. Each acquisition slab was set to in-
clude the afferent/efferent artery and aneurysmal sac with 
portions of the aorta. Twenty-five consecutive 3D volume 
images were acquired immediately after an injection of con-
trast media (0.1 mmol/kg of Gd-chelate, Magnevist: Bayer 
HealthCare, Whippany, NJ, USA) at a flow rate of 3 ml/s, 
followed by a saline flush of 30 ml during breath-holding. 
All source images from each frame were reconstructed with 
a maximum intensity projection (MIP) algorithm. 
Computed tomography scanning
Dynamic contrast CT angiography was performed at 
120 kVp with a 64-detector row scanner (Somatom Defi-
nition: Siemens, Forchheim, Germany) with a collimation 
of 64 × 0.6 mm and a pitch of 1. All scans were recon-
structed in transverse, coronal, and sagittal orientations at 
a slice thickness of 1 mm and increments of 1 mm, using 
the corresponding soft-tissue kernel B30f.
Diagnostic procedure on time-resolved magnetic 
resonance angiography and computed tomography 
angiography
On TR-MRA, all the MIP and source images were assessed 
by two experienced radiologists with experience of 13 and 
11 years, respectively, and they made diagnoses by con-
sensus. Recanalisation was diagnosed when any portion 
of the aneurysmal sac was enhanced in the arterial phase. 
For 11 lesions in nine patients for which CTA was per-
formed within two weeks before or after TR-MRA, con-
trast enhancement in the aneurysm was also assessed in 
the arterial phase by two radiologists different from the 
former ones (with 13- and 8-year experience, respectively). 
It was classified into the following three groups by con-
sensus: 1) enhanced, 2) unenhanced, and 3) unevaluable. 
Results
The mean size of the aneurysm was 10.5 cm3 (range, 0.3-132). 
For lesions treated with aneurysmal packing alone (n = 15), 
 Time-resolved magnetic resonance angiography as a follow-up method for visceral artery aneurysm treated with coil-embolisation
e139© Pol J Radiol 2018; 83: e127-e132
Figure 1. A 40-year-old woman with a splenic aneurysm. A) Computed tomography angiography (CTA) demonstrated a 24 × 18-mm aneurysm in the main 
trunk of the splenic artery (arrowhead). B-C) Digital subtraction angiography (DSA) just before and after coil embolisation showed complete occlusion of the an-
eurysm. D) Time-resolved magnetic resonance angiography showed inhomogeneous enhancement within the aneurysm in the arterial phase (arrow; axial MIP 







the mean coil-packing density was 22.4% (range, 9.5-40.0). 
The mean observation period after embolotherapy was 
35 weeks (range, 4-216). For three cases with a total of four 
lesions, follow-up DSA was performed. On TR-MRA, two 
lesions out of 21 lesions (9.5%) were diagnosed as recan-
alised. Thereafter, they were confirmed by transcatheter 
arteriography and re-treated by re-embolisation by placing 
additional coils (Figure 1). For 19 lesions (90.5%), there 
were no findings of recanalisation on TR-MRA, and ob-
servation was continued for them (Figure 2). Among the 
recanalised lesions, one lesion had been treated by aneu-
rysmal packing alone, and the other had been treated by 
proximal-to-distal embolisation alone. For the former one, 
the coil-packing density was 9.5%, lower than the mean of 
those of other lesions treated with coil packing alone (24%, 
n = 14; statistical analysis was not applicable). Among 11 le-
sions where CTA was also performed after treatment within 
two weeks before or after TR-MRA, the contrast enhance-
ment in nine lesions (82%) was unevaluable by the two ra-
diologists because of prominent metallic artefact, including 
the one recanalised lesion. Of the two lesions where the 
enhancement was detected on CTA, one lesion had been 
treated by distal-to-proximal embolisation alone, and the 
other had been treated by aneurysmal packing in addition 
to distal-to-proximal embolisation. In the latter case, recan-
alisation was not detected on TR-MRA or DSA (Figure 3). 
Table 1 shows the summary of the 21 lesions.
Discussion
In this study, we evaluated post-treated VAAs with TR-MRA 
and successfully detected recanalisation in two lesions. 
The recanalisation rate was 9.5% and was similar to those 
already reported [4, 6]. Generally, there are two major 
treatment strategies for VAAs by endovascular therapy: 
aneurysmal packing and isolation of the aneurysm by 
distal-to-proximal embolisation, using fibred and/or 
non-fibred metallic coils; sometimes they are performed 
together [8]. Because the majority of VAAs incidentally 
detected are true aneurysms, aneurysmal packing is con-
sidered favourable for their treatment compared to iso-
lation alone from the aspect of preservation of the parent 
vessel as well as preventing potential retrograde inflow 
from branches connecting to the aneurysm after treat-
ment [8]. Yasumoto et al. [6] reported, in a study with 
46 lesions of VAAs followed by CTA, that the coil-packing 
density was one of the most important keys for long-term 
clinical success, and a major cause of recanalisation was 
coil compaction, more likely to occur especially when the 
coil-packing density was relatively low. In our study, we also 
found coil compaction on the plain X-ray image of a lesion 
with recanalisation when the packing density was 9.5%. 
Therefore, it is crucial to place as many coils as possible into 
the lesion to prevent coil compaction. However, a dilemma 
presents itself when many coils are placed in a small space; 
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Figure 3. An 80-year-old woman with a right internal artery aneurysm. A) Computed tomography angio graphy (CTA) demonstrated a 35 × 35-mm aneurysm with 
a thick mural thrombus in the main trunk of the internal iliac artery just proximal to the superior gluteal artery (arrowhead). B-C) Digital subtraction angiography 
(DSA) just before and after coil embolisation showed complete occlusion of the aneurysm. D) On time-resolved magnetic resonance angiography there was no 
apparent enhancement in the aneurysm. A tiny, high-intensity area (asterisk) indicated a venous flow artefact because it was continuously observed before an 







Figure 2. A 56-year-old woman with a right re-
nal aneurysm. A) Computed tomography angio-
graphy (CTA) demonstrated an 11-mm aneurysm 
at the hilum of the right renal artery. B) Digital 
subtraction angiography showed a narrow-neck 
aneurysm (arrowhead) at the main trunk of 
the right renal artery and two efferent branches 
(arrows). C) It was treated by aneurysmal coil 
packing. D) On CTA 39 months after the treatment 
enhancement of the aneurysm was difficult to 
evaluate due to prominent metal artefacts. E) On 
time-resolved magnetic resonance angio graphy 
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1 M 1 36 SpA 3.8 213 P 9.5 Recanalization Unevaluable Recanalisation
2 F 2 56 RA 1.1 216 P 15.8 Occlusion
3 F 3 80 IIA 26.4 55 P + I N/A Occlusion Enhanced Occlusion
4 IIA 25.6 55 I N/A Recanalisation Enhanced Recanalisation
4 M 5 88 IIA 131.8 11 I N/A Occlusion
5 F 6 50 SpA 1.2 7 P 21.5 Occlusion Unevaluable Occlusion
7 SpA 1.2 15 P + I N/A Occlusion Unevaluable
6 F 8 78 SpA 0.3 13 P + I N/A Occlusion
7 F 9 64 SpA 0.8 8 P 18.6 Occlusion Unevaluable
8 F 10 72 SpA 2.2 10 P 18.9 Occlusion
9 M 11 60 SpA 2.1 10 P + I N/A Occlusion
10 M 12 46 SpA 1.5 12 P 40.0 Occlusion Unevaluable
11 F 13 74 RA 2.9 12 P 13.9 Occlusion
14 RA 3.9 12 P 17.6 Occlusion
12 F 15 80 RA 3.7 26 P 22.0 Occlusion
13 M 16 55 RA 1.0 6 P 21.0 Occlusion Unevaluable
14 M 17 70 SpA 8.5 13 P 19.6 Occlusion
15 F 18 50 SpA 1.3 9 P 24.5 Occlusion
16 F 19 56 RA 0.3 4 P 39.7 Occlusion Unevaluable
17 M 20 41 SpA 1.1 13 P 21.9 Occlusion Unevaluable
18 M 21 83 ASPD 0.2 13 P 27.9 Occlusion Unevaluable
SpA – splenic artery, RA – renal artery, IIA – internal iliac artery, ASPD – anterior superior pancreaticoduodenal artery, P – packing, I – isolation (distal-to-proximal embolisation), 
 N/A – not applicable
they produce more prominent metallic artefacts and worsen 
the visibility of contrast enhancement at the treated site on 
CTA. Furthermore, because coil compaction is an indirect 
and merely a supportive finding for recanalisation, a reliable 
tool to detect recanalisation precisely is necessary. 
The usefulness of TR-MRA has already been reported 
for post-treated intracranial aneurysms and pulmonary 
arteriovenous malformations [9, 10]. TR-MRA is one of 
the dynamic contrast-enhanced MR angiography meth-
ods and provides high-quality images while maintaining 
both adequate spatial and temporal resolutions by using 
the keyhole technique [11]. Kawai et al. [12, 13] reported 
that the advantages of TR-MRA compared to contrast-en-
hanced and/or unenhanced CT were: 1) less susceptibility 
to metallic artefacts from platinum coils, 2) detectability 
of dynamic blood flow at a high temporal resolution, and 
3) no radiation exposure. In the two cases in which recan-
alisation was confirmed on DSA in our study, intra-aneu-
rysmal blood flow was clearly shown on TR-MRA with 
a minimal signal void, whereas it was difficult to assess 
contrast enhancement on CT, especially for one lesion 
for which aneurysmal packing was performed because 
of severe metallic artefacts. Overall, for all five lesions 
confirmed by DSA, detectability of recanalisation was 
100% by TR-MRA. However, we experienced one lesion 
in which the remaining blood flow was suspected only 
on CTA but not on TR-MRA or DSA (Figure 3). It was 
hypothesised that because the timings of the CTA and 
DSA were different or the perfused area was so small, it 
could not be detected by TR-MRA or DSA. Nonetheless, 
it was considered that clinical significance might not be 
so important. On the other hand, for 9 out of 10 lesions 
treated with aneurysmal packing, contrast enhancement 
could not be evaluated on CTA because of metallic arte-
facts, including the lesion with the lowest packing density 
(9.5%). Regarding these aspects, TR-MRA might be a suit-
able modality to assess recanalisation of VAAs after coil 
embolisation, especially for lesions treated by aneurysmal 
packing, although there are a small number of contraindi-
cations: patients with internal devices (e.g. pacemakers), 
renal failure, and claustrophobia. Because the popula-
tion of patients with VAAs are relatively old and chronic 
kidney disease is relatively common, sometimes it might 
be worrisome to administer gadolinium chelate [14,15]. 
Although a former study [13] reported that a motion ar-
tefact was one of the factors affecting image quality, it was 
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acceptable in all the cases in our study. Perhaps it was be-
cause the reported cases had relatively small pulmonary 
arteriovenous malformations located in the area close 
to the apex of the left ventricle of the heart, where the 
motion of the lesion tends to be vigorous even in a good 
breath-holding state. In contrast, most of the VAAs in our 
study could be relatively stable in position as long as the 
patients could hold their breath properly. 
Dynamic contrast-enhanced MRI might be an alterna-
tive choice for detecting intra-aneurysmal blood flow [16]. 
Although it is a conventional method that could be per-
formed by general MR equipment without the specialised 
applications for keyhole imaging, the temporal resolution 
is not high enough (~15 sec or more, depending on the 
number of slices) to differentiate between direct and retro-
grade inflow from collateral pathways into the aneurysm. 
It might be a drawback for pretreatment assessment before 
re-embolisation therapy. In addition, even the lesions with 
complete occlusion sometimes appear hyperintense on 
pre-contrast MRI due to thrombi in the aneurysms, which 
makes it difficult to evaluate the contrast enhancement [17]. 
Four-dimensional computed tomography might be another 
option. Similar to TR-MRA, this method could assess hae-
modynamic states around the lesions with a high temporal 
resolution [18]. However, with the nature of X-ray CT, it 
might also be difficult to evaluate contrast enhancement of 
VAAs after treatment by placement of platinum coils.
There are some limitations to this study. First, this is 
a retrospective study with a small sample size. Second, di-
agnoses were not confirmed by transcatheter angiography 
in all cases. Nevertheless, it might have a strong potential 
for detection of blood flow in coil-embolised VAAs.
In conclusion, although this study was a small series 
and further investigation is needed, TR-MRA appears to 
be useful and highly recommended for assessment of re-
canalisation of VAAs after coil embolisation.
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